Last reviewed · How we verify
Cohort 1, Ceplene® and Proleukin® — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Cohort 1, Ceplene® and Proleukin® (Cohort 1, Ceplene® and Proleukin®) — Vastra Gotaland Region.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Cohort 1, Ceplene® and Proleukin® TARGET | Cohort 1, Ceplene® and Proleukin® | Vastra Gotaland Region | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Cohort 1, Ceplene® and Proleukin® CI watch — RSS
- Cohort 1, Ceplene® and Proleukin® CI watch — Atom
- Cohort 1, Ceplene® and Proleukin® CI watch — JSON
- Cohort 1, Ceplene® and Proleukin® alone — RSS
Cite this brief
Drug Landscape (2026). Cohort 1, Ceplene® and Proleukin® — Competitive Intelligence Brief. https://druglandscape.com/ci/cohort-1-ceplene-and-proleukin. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab